New Targeted Agents in Acute Myeloid Leukemia: New Hope on the Rise

The therapeutic approach for acute myeloid leukemia (AML) remains challenging, since over the last four decades a stagnation in standard cytotoxic treatment has been observed. But within recent years, remarkable advances in the understanding of the molecular heterogeneity and complexity of this dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Bohl, Stephan R., Bullinger, Lars, Rücker, Frank G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515298/
https://www.ncbi.nlm.nih.gov/pubmed/31018543
http://dx.doi.org/10.3390/ijms20081983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515298/
https://www.ncbi.nlm.nih.gov/pubmed/31018543
http://dx.doi.org/10.3390/ijms20081983

Ejemplares similares